Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6,887,242
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
881,553
-
Shares change
-
+33,316
-
Total reported value, excl. options
-
$2,776,892
-
Value change
-
+$105,033
-
Number of buys
-
9
-
Number of sells
-
2
-
Price
-
$3.15
Institutional Holders of Aprea Therapeutics, Inc. - Common Stock (APRE) as of Q2 2023
As of 30 Jun 2023 Aprea Therapeutics, Inc. - Common Stock (APRE) had 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 881,553 shares of stock of the company.
Largest 10 holders included AIGH Capital Management LLC, Sio Capital Management, LLC, Walleye Capital LLC, Worth Venture Partners, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, MORGAN STANLEY, BlackRock Inc., Tower Research Capital LLC (TRC), and GROUP ONE TRADING, L.P..
This table shows 19 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.